Αποτελέσματα Αναζήτησης
29 Ιουν 2022 · Carac is a cream used by adults to treat skin conditions on the face and front part of the scalp called solar keratosis or actinic keratosis. Who should not use Carac? Do not use Carac: if you are pregnant or might become pregnant. Carac may harm your unborn child. if you are nursing a baby.
What is Carac? Carac is a cream used by adults to treat skin conditions on the face and front part of the scalp called solar keratosis or actinic keratosis. Who should not use Carac? Do not use Carac: • if you are pregnant or might become pregnant. Carac may harm your unborn child. • if you are nursing a baby.
15 Ιουν 2022 · Carac Cream, 0.5% (fluorouracil) works by causing the death of cells that grow fastest, such as abnormal skin cells, and is used to treat scaly overgrowths of skin (actinic or solar keratoses). Carac Cream may also be used in the treatment of superficial basal cell carcinoma.
20 Δεκ 2023 · Generic Name: topical fluorouracil. Brand Names: Carac, Efudex, Fluoroplex, Tolak. Drug Class: Dermatologics, Other; Antineoplastics, Topical. What is topical fluorouracil, and what is it used for? Topical fluorouracil is used to treat certain skin conditions in which cells are multiplying rapidly.
1 Ιουν 2001 · The US FDA recently approved 0.5% 5-FU cream (Carac®) for the topical treatment of multiple actinic or solar keratoses on the face and anterior scalp. The cream should be applied once daily to the actinic keratoses for up to 4 weeks as tolerated by the patient.
12 Μαρ 2024 · Fluorouracil 0.5% cream (Carac) is applied directly on the affected area(s) of the face and front of the scalp once daily, for up to 4 weeks. The most common side effects of this medication are symptoms of skin irritation, such as redness, dryness, and stinging.
19 Απρ 2021 · Tirbanibulin is indicated for a once-daily application for 5 consecutive days for AKs of the face or scalp and comes in convenient single-use packets. As compared to popular 5% 5FU, which is indicated for a twice-daily application for up to one month, tirbanibulin may stand out as an appealing option for patients.
